$PDFS
PDF SOLUTIONS INC

2023 Q2 Form 10-Q Financial Statement

#000155837023008846 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $41.60M $40.76M
YoY Change 20.0% 21.68%
Cost Of Revenue $12.37M $11.90M
YoY Change 2.72% 3.25%
Gross Profit $29.23M $28.86M
YoY Change 29.2% 31.34%
Gross Profit Margin 70.27% 70.79%
Selling, General & Admin $14.77M $15.65M
YoY Change 51.14% 44.34%
% of Gross Profit 50.51% 54.22%
Research & Development $12.26M $13.05M
YoY Change -8.3% -7.37%
% of Gross Profit 41.95% 45.23%
Depreciation & Amortization $2.120M $1.304M
YoY Change -6.19% -5.51%
% of Gross Profit 7.25% 4.52%
Operating Expenses $27.03M $28.70M
YoY Change 16.79% 15.12%
Operating Profit $2.202M $159.0K
YoY Change -525.1% -105.37%
Interest Expense $1.070M $911.0K
YoY Change 7.97% 193.87%
% of Operating Profit 48.59% 572.96%
Other Income/Expense, Net
YoY Change
Pretax Income $2.947M $745.0K
YoY Change 1753.46% -125.14%
Income Tax -$3.888M $400.0K
% Of Pretax Income -131.93% 53.69%
Net Earnings $6.835M $355.0K
YoY Change -695.9% -108.55%
Net Earnings / Revenue 16.43% 0.87%
Basic Earnings Per Share $0.18 $0.01
Diluted Earnings Per Share $0.17 $0.01
COMMON SHARES
Basic Shares Outstanding 37.85M 37.77M
Diluted Shares Outstanding 39.08M 38.86M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $124.0M $133.5M
YoY Change 5.76% -0.53%
Cash & Equivalents $100.4M $114.4M
Short-Term Investments $23.70M $19.15M
Other Short-Term Assets $14.30M $9.665M
YoY Change 37.39% 9.12%
Inventory
Prepaid Expenses
Receivables $61.45M $47.05M
Other Receivables $0.00 $0.00
Total Short-Term Assets $204.4M $193.1M
YoY Change 24.78% 6.8%
LONG-TERM ASSETS
Property, Plant & Equipment $42.99M $41.72M
YoY Change 11.98% 13.24%
Goodwill $14.10M $14.10M
YoY Change 0.0% 0.0%
Intangibles $16.30M $17.18M
YoY Change -16.44% -15.68%
Long-Term Investments
YoY Change
Other Assets $7.043M $7.322M
YoY Change -12.92% -17.17%
Total Long-Term Assets $85.92M $86.15M
YoY Change 0.62% 1.68%
TOTAL ASSETS
Total Short-Term Assets $204.4M $193.1M
Total Long-Term Assets $85.92M $86.15M
Total Assets $290.3M $279.3M
YoY Change 16.5% 5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.279M $6.289M
YoY Change -32.61% 55.17%
Accrued Expenses $5.497M $5.868M
YoY Change -11.86% 27.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.08M $54.26M
YoY Change 24.6% 27.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.335M $3.367M
YoY Change -33.3% 65.54%
Total Long-Term Liabilities $6.335M $3.367M
YoY Change -33.3% 65.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.08M $54.26M
Total Long-Term Liabilities $6.335M $3.367M
Total Liabilities $66.10M $65.86M
YoY Change 28.87% 26.64%
SHAREHOLDERS EQUITY
Retained Earnings -$93.96M -$100.8M
YoY Change -8.79% -1.06%
Common Stock $6.000K $6.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $138.3M $137.8M
YoY Change 5.26% 21.02%
Treasury Stock Shares $11.32M
Shareholders Equity $224.2M $213.4M
YoY Change
Total Liabilities & Shareholders Equity $290.3M $279.3M
YoY Change 16.5% 5.16%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $6.835M $355.0K
YoY Change -695.9% -108.55%
Depreciation, Depletion And Amortization $2.120M $1.304M
YoY Change -6.19% -5.51%
Cash From Operating Activities -$5.640M -$982.0K
YoY Change -255.63% -132.78%
INVESTING ACTIVITIES
Capital Expenditures $3.100M $2.902M
YoY Change -209.85% 64.42%
Acquisitions
YoY Change
Other Investing Activities -$4.330M $649.0K
YoY Change -106.92% -95.38%
Cash From Investing Activities -$7.430M -$2.253M
YoY Change -112.44% -118.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -380.0K -2.093M
YoY Change -97.81% -70.06%
NET CHANGE
Cash From Operating Activities -5.640M -982.0K
Cash From Investing Activities -7.430M -2.253M
Cash From Financing Activities -380.0K -2.093M
Net Change In Cash -13.45M -5.242M
YoY Change -129.26% -164.6%
FREE CASH FLOW
Cash From Operating Activities -$5.640M -$982.0K
Capital Expenditures $3.100M $2.902M
Free Cash Flow -$8.740M -$3.884M
YoY Change -235.59% -415.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00015
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00015
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001120914
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-31311
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PDF SOLUTIONS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
25-1701361
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2858 De La Cruz Blvd.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95050
CY2023Q1 dei City Area Code
CityAreaCode
408
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
280-7900
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00015 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
PDFS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37852259
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114382000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119624000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
19146000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
19557000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
890000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47048000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42164000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12565000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12063000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
193141000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
193408000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41723000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40174000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5712000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6002000
CY2023Q1 us-gaap Goodwill
Goodwill
14123000
CY2022Q4 us-gaap Goodwill
Goodwill
14123000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17177000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18055000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
90000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
64000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7322000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6845000
CY2023Q1 us-gaap Assets
Assets
279288000
CY2022Q4 us-gaap Assets
Assets
278671000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6289000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6388000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13869000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16948000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5868000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5581000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1572000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1412000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26322000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
26019000
CY2023Q1 pdfs Contract With Customer Liability Billings In Excess Of Revenue Recognized
ContractWithCustomerLiabilityBillingsInExcessOfRevenueRecognized
342000
CY2022Q4 pdfs Contract With Customer Liability Billings In Excess Of Revenue Recognized
ContractWithCustomerLiabilityBillingsInExcessOfRevenueRecognized
1852000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54262000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58200000
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2637000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2622000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5597000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5932000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3367000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1905000
CY2023Q1 us-gaap Liabilities
Liabilities
65863000
CY2022Q4 us-gaap Liabilities
Liabilities
68659000
CY2023Q1 us-gaap Lease Cost
LeaseCost
615000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00015
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00015
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49150000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48613000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37836000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37431000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
454307000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447415000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
11315000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11182000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
137810000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
133709000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100795000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101150000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2283000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2550000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
213425000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
210012000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279288000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
278671000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
40759000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
33498000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
11904000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
11529000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13051000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14089000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15645000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10839000
CY2023Q1 pdfs Amortization Of Other Acquired Intangibleassets
AmortizationOfOtherAcquiredIntangibleassets
325000
CY2022Q1 pdfs Amortization Of Other Acquired Intangibleassets
AmortizationOfOtherAcquiredIntangibleassets
314000
CY2023Q1 pdfs Interest And Other Expense Income Net
InterestAndOtherExpenseIncomeNet
911000
CY2022Q1 pdfs Interest And Other Expense Income Net
InterestAndOtherExpenseIncomeNet
310000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
745000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2963000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
390000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1187000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
355000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4150000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
260000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-397000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-34000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
267000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-431000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
622000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4581000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
723000
CY2022Q1 us-gaap Lease Cost
LeaseCost
628000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37737000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37606000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38859000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37606000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
210012000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1663000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
345000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4101000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4884000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
622000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
213425000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
219585000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1502000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
675000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3389000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5778000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
5553000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4581000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
213567000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
355000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-4150000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1304000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1380000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4884000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5553000
CY2023Q1 pdfs Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
878000
CY2022Q1 pdfs Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
867000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
456000
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
173000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
231000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-37000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4872000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2296000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
973000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
976000
CY2023Q1 pdfs Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-302000
CY2022Q1 pdfs Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-918000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
476000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-278000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1261000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2069000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3132000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-864000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
260000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
582000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-225000
CY2023Q1 pdfs Increase Decrease Contract With Customer Liability Revenue Recognized
IncreaseDecreaseContractWithCustomerLiabilityRevenueRecognized
-1510000
CY2023Q1 pdfs Lease Termination Gain
LeaseTerminationGain
100000
CY2022Q1 pdfs Increase Decrease Contract With Customer Liability Revenue Recognized
IncreaseDecreaseContractWithCustomerLiabilityRevenueRecognized
245000
CY2023Q1 pdfs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-188000
CY2022Q1 pdfs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1038000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-982000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2996000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
7000000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
35000000
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6351000
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
20959000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2902000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1765000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2253000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12276000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
345000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
675000
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1663000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1502000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4101000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3389000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5778000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2093000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6990000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-167000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5242000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8115000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
119624000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27684000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
114382000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35799000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1985000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1254000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
276000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
430000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1714000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1923000
CY2023Q1 pdfs Advances For Purchase Of Fixed Assets Transferred From Prepaid Assets To Property And Equipment
AdvancesForPurchaseOfFixedAssetsTransferredFromPrepaidAssetsToPropertyAndEquipment
21000
CY2022Q1 pdfs Advances For Purchase Of Fixed Assets Transferred From Prepaid Assets To Property And Equipment
AdvancesForPurchaseOfFixedAssetsTransferredFromPrepaidAssetsToPropertyAndEquipment
120000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include revenue recognition, the estimated useful lives of property and equipment and intangible assets, assumptions made in analysis of allowance for credit losses, impairment of goodwill and long-lived assets, valuation for deferred tax assets, and accounting for lease obligations, stock-based compensation expense, and income tax uncertainties and contingencies. Actual results could differ from those estimates and may result in material effects on the Company’s operating results and financial position.</p>
CY2023Q1 pdfs Number Of Revenue Sources
NumberOfRevenueSources
2
CY2023Q1 pdfs Percent Of Revenue
PercentOfRevenue
1
CY2022Q1 pdfs Percent Of Revenue
PercentOfRevenue
1
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2900000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3300000
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
261200000
CY2023Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2500000
CY2022Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
200000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q1 pdfs Shortterm And Variable Lease Cost
ShorttermAndVariableLeaseCost
283000
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
16100000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
13500000
CY2023Q1 pdfs Unbilled Receivables Not Expected To Be Billed And Collected In Next Twelve Months
UnbilledReceivablesNotExpectedToBeBilledAndCollectedInNextTwelveMonths
700000
CY2022Q4 pdfs Unbilled Receivables Not Expected To Be Billed And Collected In Next Twelve Months
UnbilledReceivablesNotExpectedToBeBilledAndCollectedInNextTwelveMonths
800000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
89234000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
86369000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47511000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46195000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41723000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40174000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1300000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1400000
CY2023Q1 us-gaap Goodwill
Goodwill
14100000
CY2022Q4 us-gaap Goodwill
Goodwill
14100000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
47588000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30411000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17177000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
47588000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29533000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18055000
CY2023Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y8M12D
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
878000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
867000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2613000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3093000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2928000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2759000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2606000
CY2023Q1 pdfs Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
3178000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17177000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q1 pdfs Number Of Finance Leases
NumberOfFinanceLeases
0
CY2022Q4 pdfs Number Of Finance Leases
NumberOfFinanceLeases
0
CY2022Q1 pdfs Operating Lease Right Of Use Asset Adjustment For Early Termination
OperatingLeaseRightOfUseAssetAdjustmentForEarlyTermination
500000
CY2022Q1 pdfs Operating Lease Liability Adjustment For Early Lease Termination
OperatingLeaseLiabilityAdjustmentForEarlyLeaseTermination
600000
CY2023Q1 pdfs Lease Termination Expense
LeaseTerminationExpense
-100000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
387000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
345000
CY2023Q1 pdfs Shortterm And Variable Lease Cost
ShorttermAndVariableLeaseCost
228000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1122000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0487
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0487
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1299000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1638000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1551000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1357000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1294000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
991000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8130000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
961000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7169000
CY2023Q1 pdfs Operating Lease Liability Amount Related To Extension Of Lease Term
OperatingLeaseLiabilityAmountRelatedToExtensionOfLeaseTerm
900000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1600000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38859000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37606000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4884000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5553000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
68000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.11
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
47000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.98
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M29D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1248000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
47000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.97
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y6M21D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1242000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
39000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.81
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M9D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1038000
CY2023Q1 us-gaap Share Price
SharePrice
42.40
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
400000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37606000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2124000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
21.29
CY2023Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
800000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.52
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.400
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15200000
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000.0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15100000
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000.0
CY2023Q1 pdfs Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued In Long Term Liabilities
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedInLongTermLiabilities
2600000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000
CY2023Q1 pdfs Unrecognized Tax Benefits In Deferred Tax Assets
UnrecognizedTaxBenefitsInDeferredTaxAssets
13200000
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
59200000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
59200000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
355000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4150000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37737000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1101000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
47435000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
46176000
CY2023Q1 pdfs Cash Cash Equivalents Short Term Investments Fair Value Disclosure
CashCashEquivalentsShortTermInvestmentsFairValueDisclosure
98349000
CY2022Q4 pdfs Cash Cash Equivalents Short Term Investments Fair Value Disclosure
CashCashEquivalentsShortTermInvestmentsFairValueDisclosure
97285000
CY2023Q1 pdfs Term Of Product Warranty
TermOfProductWarranty
P90D
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
25700000
CY2023Q1 pdfs Threshold Payment Period Of Majority Of Purchase Obligation
ThresholdPaymentPeriodOfMajorityOfPurchaseObligation
P24M

Files In Submission

Name View Source Status
pdfs-20230331_cal.xml Edgar Link unprocessable
0001558370-23-008846-index-headers.html Edgar Link pending
0001558370-23-008846-index.html Edgar Link pending
0001558370-23-008846.txt Edgar Link pending
0001558370-23-008846-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pdfs-20230331.xsd Edgar Link pending
pdfs-20230331x10q.htm Edgar Link pending
pdfs-20230331xex31d01.htm Edgar Link pending
pdfs-20230331xex31d02.htm Edgar Link pending
pdfs-20230331xex32d01.htm Edgar Link pending
pdfs-20230331xex32d02.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pdfs-20230331_def.xml Edgar Link unprocessable
pdfs-20230331_lab.xml Edgar Link unprocessable
pdfs-20230331_pre.xml Edgar Link unprocessable
pdfs-20230331x10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending